Marika Murto brings over 20 years of pharmaceutical expertise in product strategy, innovation, and business transformationHer ...

Atom Therapeutics, a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic diseases, today announced FDA approval of a Phase II clinical trial ...

The outpatient clinics market is projected to expand at a compound annual growth rate (CAGR) of 8% over the forecast period.

PARIS, FRANCE / ACCESS Newswire / December 16, 2025 / One year after deploying CaloPix®, the digital pathology platform developed by Tribun Health, NOVO Hospital (Val-d'Oise, France) reports clear, ...

GERMANTOWN, MD AND CHICAGO, IL / ACCESS Newswire / December 16, 2025 / uBriGene Biosciences, a leading global lentivirus CDMO specializing in Advanced Therapy Medicinal Product (ATMP) GMP development ...

A New Era of Smart Access, Enhanced Living, and Turnkey Revenue Opportunities.TORONTO--(BUSINESS WIRE)--As resident expectations evolve and buildings compete on experience, Snaile, Canada’s award ...

CTT Pharmaceutical Holdings, Inc. is pleased to announce that a peer-reviewed scientific paper has been published in the journal of Drug Delivery and Therapeutics, authored by our scientist Dr.

Today, Latent Labs announces Latent-X2, a frontier AI model that can design drug-like biologics without iteration. Drug hunters can use Latent Lab's AI platform, built on Latent-X2, to access ...

Glasgow Caledonian University has secured £2.6 million to lead a major new UK-wide doctoral training programme to spearhead research into oral health and dental disease prevention.Funded by the ...

Convenient subcutaneous option has potential to reach more patients with same clinical benefits as Saphnelo IV infusionAstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union (EU) ...

Linus Health, an AI-driven brain health company pioneering early detection of cognitive impairment and personalized intervention, today announced the appointment of former Academy of Family Physicians ...

First and only transgenic chicken platform engineered to express ultralong CDRH3 domains on a human antibody framework ...